aptaTargets transferred ApTOLL to Merck 26/05/2025 Healthcare Access to innovation Financing ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical... Partners - AptaTargets
Repronovo raises $65 million Series A financing to advance phase 2 clinical trials of nove... 21/05/2025 Healthcare Financing Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and... Partners - Ysios Capital Partners
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Healthcare Access to innovation Financing Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnosti... 29/04/2025 Healthcare Access to innovation Financing Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners Partners - Asabys Partners
ORYZON capta 30 millones de euros en una ampliación de capital internacional 24/04/2025 Financing Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP Partners - Oryzon Genomics
AseBio participates in the Moncloa meeting with the main business associations to discuss ... 03/04/2025 Financing AseBio will closely monitor developments and analyze the implications that the tariffs imposed by the United States may... AseBio
Investment in R&D by spanish biotech companies increases by 7.1% in 2023, surpassing 2.7 b... 26/02/2025 Healthcare Agrifood Financing Talento According to the INE report, if we exclusively analyze the figure for companies, we observe that R&D investment... AseBio
ZYMVOL raises €3 million in seed funding 20/02/2025 Healthcare Innovative drugs Financing Partners - Zymvol Biomodeling
EIB finances with €15 million Amadix to develop innovative diagnostic tests for early canc... 11/02/2025 Healthcare Innovative drugs Advanced therapies EU projects Financing Amadix is a Spanish biotech company developing non-invasive blood tests for early detection of several types of cancer... Partners - Amadix
